On Dec. 18, 2017, the Colombian medical cannabis market took a major step forward with the opening of a medical cannabis research and development lab.
Tag Archives: R&D
While the United States Drug Enforcement Agency’s marijuana research license isn’t awarded lightly, an Ohio-based organization was recently awarded a Schedule I Researcher license by the DEA to study the effects of marijuana.
COLUMBUS, Ohio, Oct. 31, 2017 /Weed Wire/ — Battelle announced today that it was awarded a Schedule I Researcher license by the U.S. Drug Enforcement Administration (DEA), paving the way for the leading research and development organization to conduct marijuana research with human subjects.
INDUSTRY, Calif., Aug. 24, 2017 /Weed Wire/ — Sugarmade, Inc. (OTCQB:SGMD), today announces new details of its upcoming BudLife product line, the first patented, container system designed to maintain the integrity of cannabis during long-term storage. Sugarmade and its manufacturing partner, Plantation Corp., have been testing several prototype versions of BudLife over the past few months.
Puerto Rico medical cannabis legalization has become a legislative reality. On July 9, 2017, Puerto Rico Gov. Ricardo Rosselló Nevares signed the Law to Improve the Study, Development and Research of Cannabis for Innovation, Applicable Norms and Limits, also known as MEDICINAL Law, to regulate medical cannabis on the Caribbean island.
LA FORTALEZA, P.R., July 9, 2017 /Weed Wire/ — Governor Ricardo Rosselló Nevares today signed the Law to Improve the Study, Development and Research of Cannabis for Innovation, Applicable Norms and Limits (MEDICINAL Law), which regulates the use of medicinal cannabis in Puerto Rico, in order to comply with one of the commitments contained in the Plan for Puerto Rico.
OXNARD, Calif., May 31, 2017 /Weed Wire/ — CURE Pharmaceutical (OTCQB: CURR), (“CURE”), a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development company, announced today that the company’s partnership with CannaKids has entered into a strategic research collaboration with Technion Research and Development Foundation Ltd., a wholly owned subsidiary of the Technion Israel Institute of Technology, in order to research how different cannabinoid compounds within cannabis strains can be used to treat various subtypes of cancer.
On May 30, 2017, Cann Group Limited, an Australian medical cannabis company, announced that it had obtained the permits required to start cultivating medical cannabis and should begin its cultivation operation in the next few days.
TEL AVIV, Isarel, March 10, 2016 /Weed Wire/ — iCAN- Israel Cannabis and Breath of Life Pharma (BOL Pharma) announced a new partnership to form the first private cannabis R&D incubator center in Israel.
The Med-X management team has built a cannabis company that focuses on ancillary products, research and development, and education.
VapeXhale is positioning itself as a technology company within the cannabis industry because it realizes the technology convergence that is not only occurring but approaching.
Have you ever heard of ebbu before? Until a week ago, I hadn’t either, and I make it my business to keep my ear pretty low to the ground on such things.